Summit Therapeutics Plc (SUMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Summit Therapeutics Plc (SUMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summit Therapeutics Plc (SUMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Summit Therapeutics Plc (SUMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
28 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Summit Therapeutics Plc (Summit) formerly Summit Corporation Plc is a drug discovery and development company that undertakes development of advancing novel therapies to treat areas of high unmet medical need. The companys research and development activities concentrates on the treatment of duchenne muscular dystrophy and the infectious disease caused by the bacteria C. difficile. It undertakes utrophin modulation programme for duchenne muscular dystrophy. Summit develops novel antibiotic programme for the treatment of superbug C. difficile. The company collaborates with a wide range of pharmaceutical and biotechnology companies, and charity foundations and parent advocacy groups.

Summit Therapeutics Plc (SUMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have

  
Source:
Document ID
GDPH82279D
Country
Industry
Ticker
SUMM=GB
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Summit Therapeutics Plc, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Summit Therapeutics Plc, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Summit Therapeutics Plc, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Summit Therapeutics Plc, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201682
Summit Therapeutics Plc, Medical Devices Deals, 2010 to YTD 2016101
Summit Therapeutics Plc, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016111
Summit Therapeutics Plc, Pharmaceuticals &Healthcare, Deal Details1213
  Partnerships121
    Summit Therapeutics Enters into Agreement with University of Oxford121
  Licensing Agreements131
    Summit Enters Into Licensing Agreement With Bristol-Myers Squibb For Seglin Technology131
  Equity Offering141
    Summit Therapeutics Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants141
    Summit Therapeutics Completes Initial Public Offering of American Depositary Shares152
    Summit Completes Private Placement Of Shares For US$34.4 Million171
    Summit Completes Private Placement Of Shares For US$1.6 Million181
    Summit Completes Private Placement Of Shares For US$7 Million191
    Summit Completes Private Placement Of Shares For US$0.1 Million201
    Summit Announces Private Placement Of Shares For US$8 Million212
    Summit Completes Private Placement Of Common Stock For US$2.2 Million231
  Acquisition241
    Summit Acquires MuOx for USD5.3 Million241
Summit Therapeutics Plc - Key Competitors251
Key Employees261
Locations And Subsidiaries271
  Head Office271
  Other Locations &Subsidiaries271
Appendix281
  Methodology281
  About GlobalData281
  Contact Us281
  Disclaimer281

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Summit Therapeutics Plc (SUMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Summit-Therapeutics-Plc-SUMM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7797>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Summit Therapeutics Plc (SUMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Summit-Therapeutics-Plc-SUMM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7797>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research